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The aim of this study was to analyse the quality of life in osteoporotic patients with hip fracture and those 
without fractures. The study included postmenopausal women, 35 with hip fracture and 33 without fractures. 
The control group included 44 age–matched healthy women. Osteoporosis Quality of Life Questionnaire 
was used to assess the health–related quality of life (HRQL). Patients with hip fracture had significantly 
lower scores in symptoms, physical function and leisure (P<0.05), than patients without fractures. Both 
groups of patients had significantly lower scores than controls in all domains except Leisure. Analysing 
several health and social factors that could influence HRQL, we found that bone mass in spine and femoral 
neck significantly correlated with HRQL. Since patients with osteoporosis usually have no symptoms 
before fracture, early diagnosis and the treatment of the disease are of key importance to the quality of 
life in these patients.
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Osteoporosis is an important health care problem 
worldwide, and it has physical, mental and social 
implications on women’s lives. The most serious 
consequence of osteoporosis is hip fracture, which 
usually adversely affects health–related quality of life 
(HRQL). Therefore, HRQL has become an important 
outcome for studies of osteoporotic and hip–fractured 
patients. Most have demonstrated impaired quality 
of life in those patients (1–10). Several generic 
instruments have been developed in order to assess 
HRQL (11–12), but they give a general estimate of 
health and are not specific for osteoporosis. Recently, 
a number of osteoporosis–targeted questionnaires 
have been designed for patients with hip or vertebral 
fracture (13–16). One of them is Osteoporosis 
Quality of Life Questionnaire, developed by National 
Osteoporosis Foundation (13).
In this study, we investigated the quality of life in 
osteoporotic patients with hip fractures and without 
fractures and compared them with healthy controls. 
The main purpose of this investigation was to assess 
whether osteoporosis, which is known as a “silent 
disease”, could significantly impair the quality of life 
in patients who had not experienced fractures.
SUBJECTS AND METHODS
Subjects
The study included 35 women with hip fracture, 
27 with pertrochanteric and 8 with subtrochanteric 
fractures. The mean age was 71.6±9.8 years. All 
fractures were caused by a fall while standing or 
walking. Hip metastatic fractures were excluded. 
All hip–fractured patients underwent a surgery 
(osteosynthesis or partial endoprothesis) between 
1995 and 2000 and were successfully rehabilitated.
A group of 33 women with established 
osteoporosis of spine or femoral neck, but with no 
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history of fractures, was selected for comparison. The 
mean age was 69.5±7.0 years. These subjects were 
recruited from the osteoporosis outpatient’s practice 
of the Institute for Medical Research and Occupational 
Health, Zagreb, Croatia.
Medical records were used to identify eligible 
patients for either group, who were then invited to 
participate in the study. The exclusion criteria was the 
history of major health problems which could seriously 
affect the patient’s quality of life such as cognitive or 
emotional impairments or secondary causes of bone 
loss such as hyperparathyroidism, hyperthyroidism, 
Paget’s disease and multiple myeloma.
The control group comprised 44 healthy 
women. They had no history of diseases which 
affected bone metabolism such as hyperthyroidism, 
hyperparathyroidism, chronic gastrointestinal 
diseases, prolonged immobilisation or prolonged 
corticosteroid therapy. The mean age of the controls 
was 68.6±6.7 years.
Testing and Measurement
Two physicians conducted the interviews. The 
instrument for testing HRQL was Osteoporosis Quality 
of Life Questionnaire (OQLQ). It was designed as a 
disease–specific questionnaire for postmenopausal 
women with osteoporosis (13). Thirty questions are 
grouped in five domains as follows:
– Symptoms (physical experiences associated   
with osteoporosis; 9 items);
– Emotional Function (affective components   
associated with osteoporosis; 4 items);
– Physical Function (difficulties with components 
  of activities of daily living; 5 items);
– Activities of Daily Living (housework, self–care, 
  shopping; 8 items);
– Leisure and Social Activities (recreational   
  activities; 4 items).
Each item had a seven–point scale, with point 7 
representing the best possible function and point 1 the 
worst possible function. We calculated the score for 
each of the five domains by summing up the points 
and dividing them with the number of items in each 
domain. The higher the score the better the function 
in each domain of quality of life. Besides the separate 
domain scores, HRQL is also reported as an aggregate 
score for all five domains.
All participants were measured bone density using 
the DXA system (GE Lunar Prodigy). Bone mineral 
density (BMD; g/cm2) was measured at the lumbar 
spine (L2–L4) and left femoral neck or right femoral 
neck in those patients who underwent an operation 
of the left hip. Osteoporosis was diagnosed according 
to the WHO criteria (17), that is, T–score lower than 
–2.5 standard deviations was defined as osteoporosis. 
T score represents the number of standard deviations 
with respect to the mean BMD of control population 
between 20 and 40 years using the manufacturer’s 
reference values.
Statistical Analysis
The results are expressed as means ± standard 
deviations. Differences in means were tested by 
the Student’s t–test. The effect of age, duration of 
postmenopause, and several other health and social 
parameters on HRQL were tested using the multiple 
regression analysis. The value P<0.05 was considered 
significant in all statistical tests.
RESULTS
A total of 112 women completed the questionnaire. 
On average, each questionnaire took 35 minutes to 
complete. Table 1 shows the clinical and social 
profile of the subjects. Patients with hip fracture had 
a significantly lower BMD in the femoral neck (P<0.05) 
than those without fracture. Spinal osteoporosis was 
found in 15 fracture patients and 28 patients without 
fracture, while osteoporosis of the femoral neck 
was diagnosed in 18 patients with hip fracture and 
9 without fracture. In the control group, T–score 
showed osteopoenia in 6 women, but their BMD, 
age–matched values were normal. Controls had a 
significantly higher BMD of the spine and femoral 
neck than patients with osteoporosis (P<0.0001). 
Patients without fracture were receiving significantly 
more bisphosphonates than the hip–fractured group 
(P=0.05) or controls (P<0.0001). All groups had 
similar education. Fracture patients were older and 
the group counted more widows, but those differences 
were not significant.
Figure 1 shows the differences in domain scores 
between the groups. Save for Leisure, healthy women 
showed significantly higher scores in all domains than 
osteoporotic patients (P<0.0001 for Symptoms, 
Physical Function; P<0.05 for Emotional Function 
and Activities of Daily Living) and patients with hip 
fracture (P<0.05 for Emotional Function; P<0.0001 
for other domains). Osteoporotic patients without 
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                     Patients with osteoporosis
Hip fracture No fracture Healthy subjects
N=35 N=33 N=44
Age (yrs) 71.6±9.8 69.5±7.0 68.6±6.7
Years since MP* 24.0±10.4 22.3±7.5 20.5±5.8
Years after fracture 3.8±0.6 / /
Marital status:    
          Married 14 18 34
          Single 2 3 2
          Widowed 16 9 7
          Divorced 3 4 1
Education:    
          Elementary 11 10 12
          High school 17 14 23
          University 7 9 9
Medications:    
         Calcium 5 2 10
         HRT** 1 4 7
         Bisphosphonates  61 15  13
BMD(g/cm2)***:    
         Spine BMD*** 0.921±0.1442,3 0.830±0.067 1.109±0.8993
         Femoral neck BMD 0.646±0.1753 0.734±0.109 0.881±0.0773
Table 1 Profile of study groups
* MP=menopause; **HRT= hormone replacement therapy; *** BMD=bone mineral density 
1P<0.05 bisphosphonates therapy hip fractured vs. unfractured patients; 2P=0.01 spine BMD hip fractured vs. unfractured patients; 3P<0.0001 
bisphosphonates therapy controls vs. unfractured patients; spine BMD controls vs. fractured and unfractured patients; femoral neck BMD controls vs. 
fractured and unfractured patients
Figure 1 Mean OQLQ scores through 5 domains in osteoporotic patients and controls
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fractures had significantly higher (better) scores for 
Symptoms (P<0.05), Physical Function (P<0.05) and 
Leisure and Social Activities (P<0.05) than patients 
with hip fracture. No significant differences were found 
in the domains of Emotional Function and Activities 
of Daily Living between the two groups of patients. 
Among fracture patients, no significant correlation 
was found between OQLQ scores and the time past 
since hip fracture.
We performed regression analysis with HLQL as 
an independent variable and a number of dependent 
variables (age, duration of postmenopause, BMD, 
medications, education and marital status) (Table 2). 
Bone mineral density of the femoral neck significantly 
correlated with HLQL in all groups (P<0.05). In the 
control group, spinal BMD also significantly correlated 
with HLQL (P<0.05).
DISCUSSION
This study has demonstrated that hip–fractured 
patients experience a significant deterioration in 
HRQL. In this group of patients, OQLQ has shown a 
departure in physical and emotional parameters from 
subjects who had osteoporosis without fracture or 
from controls. This stresses the importance of early 
diagnosis and prevention of osteoporosis. Being a 
“silent disease”, it could go unnoticed for as long as 
there is no fracture.
The assessment of osteoporosis associated with 
hip fracture is important for developing effective 
treatment and rehabilitation of those patients. Several 
studies have assessed the effects of osteoporosis and 
fractures on HRQL. In a prospective case–control 
study, Randell and co–workers (1) demonstrated 
that quality of life was significantly lowered by hip 
fracture, and concluded that HRQL should make a 
part of the assessment of osteoporosis–associated 
morbidity and costs. In a sample of 194 elderly 
women who were at high risk of hip fracture, Salkeld 
and co–workers (4) found that quality of life was 
profoundly threatened by falls and hip fractures. 
Tosteson and co–workers (5) concluded that negative 
impact of hip and vertebral fractures on quality of life 
years must be accounted in the economic value of 
the interventions in osteoporosis. In a study of 105 
osteoporotic elderly women (2), spinal fractures and 
several socio–demographic factors proved important 
for quality of life, while hip fracture and bone density 
were not significant.
However, HRQL questionnaires used were not 
uniform for all studies, particularly since osteoporosis–
targeted questionnaires are of a quite recent date. 
Osteoporosis Quality of Life Questionnaire was 
designed as a disease–specific questionnaire for 
postmenopausal women suffering from chronic pain 
due to osteoporosis. While generic questionnaires 
allow better comparison between populations 
suffering from different diseases, OQLQ provides 
more detailed information about morbidity caused 
by osteoporosis. The OQLQ has proven repeatable, 
coherent and discriminating well between osteoporotic 
and healthy subjects (13).
In this study, hip–fractured patients showed 
lower quality of life in three domains with respect to 
non–fractured patients: emotions, physical functions 
and leisure. Adachi and co–workers also found that 
HRQL was lower for physical function in patients 
who had hip fracture (9). Activities of daily living 
did not significantly change, which suggests that 
postoperative rehabilitation in these patients was 
good. In a study of 50 patients with Colles’ fracture, 
Dolan and co–workers (7) found a significant drop 
in HRQL after the fracture followed by a significant 
rise after treatment.
                                                   Patients with osteoporosis  Healthy subjects
Hip fracture No fracture 
N=44 N=35 N=33
Age 0.072 0.374 –0.477
Duration of PM –0.274 0.254 –0.311
BMD spine 0.150 0.644    0.6121
BMD femoral neck 0.5451   0.2311    0.6661
Medications 0.148 0.397  0.151
Education 0.064 0.288  0.114
Marital status 0.052   0.4261  0.224
Results in the table are expressed as beta values.
1P<0.05 (multiple regression analysis)
Table 2 Associations between HRQL and clinical profile of study groups
–
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Osteoporosis and especially its most serious 
consequence, hip fracture, have a significant 
influence on health–related quality of life measured 
using the OQLQ. The lack of “objective” symptoms 
can often conceal the deteriorated quality of life 
in osteoporotic patients without fracture. Beside 
the comparison between osteoporotic and healthy 
people, we analysed the differences in quality of life 
between two groups of osteoporotic patients: those 
without fractures and those with hip fracture and 
found that the latter suffered even lower quality of 
life. Since osteoporosis is a widespread disease, an 
evaluation of fracture–associated morbidity, including 
social, emotional and physical functioning could help 
to develop more effective preventive and therapeutic 
measures for osteoporosis.
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Sažetak
KVALITETA ŽIVOTA U BOLESNICA S OSTEOPOROZOM S PRIJELOMOM KUKA I U ONIH BEZ 
PRIJELOMA
Osteoporoza je bolest visoke prevalencije i poznata je kao “tiha epidemija” jer ne uzrokuje značajnije 
simptome sve do pojave prijeloma kostiju. Budući da osteoporotski prijelomi, osobito prijelom kuka, 
imaju ozbiljne zdravstvene i socijalne posljedice, kvaliteta života bolesnika nakon prijeloma postala je 
predmetom mnogih istraživanja o osteoporozi. U ovome ispitivanju analizirana je razlika u kvaliteti života 
između bolesnika s osteoporotskim prijelomom kuka i bolesnika s osteoporozom ali bez prijeloma. 
Sudjelovalo je 35 žena s prijelomom kuka i 33 žene s utvrđenom osteoporozom ali bez prijeloma. Sve 
ispitanice bile su u postmenopauzi i svima je učinjena denzitometrija skeleta. Za procjenu kvalitete života 
rabljen je upitnik Osteoporosis Quality of Life Questionnaire, koji se sastoji od 30 pitanja podijeljenih u pet 
kategorija: Simptomi, Emotivne funkcije, Fizičke funkcije, Aktivnosti dnevnog života i Socijalne aktivnosti 
i dokolica. Ispitanice s prijelomom kuka imale su značajno lošije vrijednosti nego žene bez prijeloma u 
kategorijama: Simptomi, Fizičke funkcije i Socijalne aktivnosti i dokolica. Obje grupe bolesnica imale su 
značajno niže vrijednosti pokazatelja kvalitete života u odnosu na kontrolnu skupinu žena bez koštanih 
bolesti. Analizom zdravstvenih i socijalnih parametara utvrđeno je da mineralna gustoća (osteoporoza) 
kralježnice i kuka imaju statistički značajan utjecaj na kvalitetu života. Zaključujemo da su rana dijagnoza 
i liječenje osteoporoze prije pojave prijeloma važni za izbjegavanje zdravstvenih i socijalnih teškoća i pada 
kvalitete života u bolesnika s osteoporozom.
KLJUČNE RIJEČI:  denzitometrija skeleta, društveni čimbenici, emotivne funkcije, fizičke funkcije, 
                operativno liječenje, tiha epidemija
